Leaflet PHLOGENZYM gastro-resistant tablets
Indicated for: inflammation; post-traumatic edema
Route of administration: oral
Substance: rutoside + bromelain + trypsin (vasodilator + enzyme + anti-inflammatory agent)
ATC: M09AB52 (Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Enzymes)
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Rutoside+bromelain+trypsin is a combination of substances used to reduce inflammation and support vascular health. Rutoside strengthens capillary walls and reduces their fragility, bromelain is an enzyme extracted from pineapple with anti-inflammatory and proteolytic properties, and trypsin is an enzyme that helps break down proteins and reduce edema.
This combination is commonly used in the treatment of inflammatory conditions such as post-traumatic edema, chronic venous insufficiency, and other conditions associated with inflammation and capillary fragility. It is available in tablet or capsule form.
Side effects are rare but may include gastric discomfort, diarrhea, or allergic reactions. It is important to take it as directed by a healthcare professional, especially for long-term use.
Rutoside+bromelain+trypsin is an effective combination for reducing inflammation and supporting vascular health, offering multiple benefits for patients with inflammatory conditions.
General data about PHLOGENZYM
- Substance: rutoside + bromelain + trypsin
- Date of last drug list: 01-07-2021
- Commercial code: W59759005
- Pharmaceutical form: gastro-resistant tablets
- Quantity: 100
- Product type: generic
- Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.